Files in This Item:
 | WHO-HIV-2017.23-eng.pdfView/Open |
| Title: | Transition to new antiretroviral drugs in HIV programmes: clinical and programmatic considerations |
| Authors: | World Health Organization |
| Issue Date: | 2017 |
| Publisher: | World Health Organization |
| Place of publication: | Geneva |
| Language: | English |
| Description: | 40 p. |
| Subject: | HIV HIV Infections Anti-Retroviral Agents Anti-HIV Agents Clinical Medicine |
| Gov't Doc #: | WHO/HIV/2017.23 |
| URI: | http://www.who.int/iris/handle/10665/255887 |
| License: | CC BY-NC-SA 3.0 IGO |
| License URL: | https://creativecommons.org/licenses/by-nc-sa/3.0/igo |
| Appears in Collections: | Technical Documents |
Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.